FMR1-217 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,709 results for “FMR1-217”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

A Study to Evaluate SAGE-217 in Participants With Essential Tremor

34 participants · First posted Dec 1, 2016

A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

35 participants · First posted Oct 2, 2018

A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder

581 participants · First posted Sep 14, 2018

A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder

102 participants · First posted Dec 22, 2016

A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

53 participants · First posted Jul 5, 2019

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)

1,515 participants · First posted Mar 6, 2019

A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease

29 participants · First posted Dec 22, 2016

Analysis of Oculo-motor Deficiencies Associated With FMR1 Gene Expression (Genetic Abnormality Predisposing to a Neurodegenerative Disease)

27 participants · First posted Sep 30, 2008

Dexmedetomidine on Postoperative Cognitive Dysfunction and Serum Tau-217 Protein.

94 participants · First posted Apr 15, 2024

Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma

100 participants · First posted Dec 30, 2019

Page 1 of 150